Notice2022-12589

National Cancer Institute; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
June 10, 2022

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 112 (Friday, June 10, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 112 (Friday, June 10, 2022)]
[Notices]
[Pages 35561-35562]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-12589]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C.,

[[Page 35562]]

as amended. The grant applications and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Collaborative Research at the NIH Clinical Center (U01).
    Date: July 7, 2022.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W240, Rockville, Maryland 20850 (Virtual 
Meeting).
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609, Medical Center Drive, Room 
7W240, Rockville, Maryland 20850, 240-276-5122, 
<a href="/cdn-cgi/l/email-protection#aac2cbd9cbc484d9c3cecec3dbdfc3eac4c3c284cdc5dc"><span class="__cf_email__" data-cfemail="90f8f1e3f1febee3f9f4f4f9e1e5f9d0fef9f8bef7ffe6">[email&#160;protected]</span></a>.

    Name of Committee: National Cancer Institute Initial Review 
Group; Cancer Centers Study Section (A).
    Date: August 4, 2022.
    Time: 10:30 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W530, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Shamala K. Srinivas, Ph.D., Associate Director, 
Office of Referral, Review, and Program Coordination, Division of 
Extramural Activities, National Cancer Institute, NIH 9609, Medical 
Center Drive, Room 7W530, Rockville, Maryland 20850, 240-276-6442, 
<a href="/cdn-cgi/l/email-protection#1b68682e282c6f5b757273357c746d"><span class="__cf_email__" data-cfemail="61121254525615210f08094f060e17">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 7, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-12589 Filed 6-9-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on June 10, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.